Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website https://www.jofem.org |
Case Report
Volume 12, Number 6, December 2022, pages 202-208
Conversion From Hypothyroidism to Hyperthyroidism and Back After Anti-SARS-CoV-2 Vaccination
Figure
Table
TSH, µIU/mL (0.5 - 4.2) | FT4, pmol/L (10.5 - 18.9) | FT3, pmol/L (4.2 - 7.4) | Levothyroxine dose, µg/day | |
---|---|---|---|---|
aPersistent hypothyroidism converted to euthyroidism after the first dose of the vaccine (April 13, 2021) and to hyperthyroidism after the second dose of the vaccine. SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; TSH: thyroid-stimulating hormone; FT4: free thyroxin; FT3: free triiodothyronine. | ||||
November 13, 2020 | 7.0 | - | - | 100 |
February 19, 2021 | 8.7 | 3.7 | - | 100 |
April 13, 2021 | 1.2 | 4.5 | 14.5 | 100 |
May 13, 2021 | 0.13 | - | - | 100 |
June 23, 2021 | 0.073 | 22.9 | - | 0 |
July 24, 2021 | 43.7 | 6.0 | 2.3 | 0 |